1. Home
  2. ROIV vs WST Comparison

ROIV vs WST Comparison

Compare ROIV & WST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$30.28

Market Cap

21.0B

Sector

Health Care

ML Signal

HOLD

Logo West Pharmaceutical Services Inc.

WST

West Pharmaceutical Services Inc.

HOLD

Current Price

$327.67

Market Cap

18.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROIV
WST
Founded
2014
1923
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.0B
18.5B
IPO Year
2021
2004

Fundamental Metrics

Financial Performance
Metric
ROIV
WST
Price
$30.28
$327.67
Analyst Decision
Strong Buy
Buy
Analyst Count
9
7
Target Price
$28.94
$325.86
AVG Volume (30 Days)
5.9M
586.8K
Earning Date
05-28-2026
04-23-2026
Dividend Yield
N/A
0.30%
EPS Growth
N/A
1.49
EPS
N/A
1.92
Revenue
$8,260,000.00
$2,886,900,000.00
Revenue This Year
N/A
$6.76
Revenue Next Year
$744.61
$6.22
P/E Ratio
N/A
$172.34
Revenue Growth
N/A
1.95
52 Week Low
$10.71
$206.80
52 Week High
$32.79
$336.82

Technical Indicators

Market Signals
Indicator
ROIV
WST
Relative Strength Index (RSI) 56.52 61.73
Support Level $27.44 $253.53
Resistance Level $32.79 N/A
Average True Range (ATR) 0.87 8.03
MACD 0.01 0.18
Stochastic Oscillator 86.99 67.72

Price Performance

Historical Comparison
ROIV
WST

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About WST West Pharmaceutical Services Inc.

West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.

Share on Social Networks: